Peak Pharmaceuticals (OTCMKTS:PKPH) Shares Down 13.5%

Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Free Report)’s stock price was down 13.5% on Wednesday . The stock traded as low as $4.50 and last traded at $4.50. Approximately 393 shares traded hands during trading, a decline of 96% from the average daily volume of 9,053 shares. The stock had previously closed at $5.20.

Peak Pharmaceuticals Trading Down 13.5 %

The company has a fifty day moving average price of $3.82 and a two-hundred day moving average price of $2.92.

Peak Pharmaceuticals Company Profile

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

See Also

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.